![NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]](https://www.clinicalomics.com/wp-content/uploads/2019/01/304-218x150.jpeg "Polygenic Risk Scores Predict Heart Disease Across Diverse Populations")
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company
Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...
Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina
From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.
Liquid Biopsies Provide Precision Approach to Ovarian Cancer Treatment
Scientists based at the University of Helsinki reported they were able to use the circulating tumor DNA shed by ovarian tumors to identify clinically actionable mutations and provide targeted treatments to patients.
FDA Sends Warning Letter to Inova Over Pharmacogenomics Test
The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
Clinical Urologists Group Supports Genomic Testing for Prostate Cancer
AACU statement encourages use of tissue-based molecular testing and/or germline testing for three groups of prostate cancer patients
Proteogenomic Colon Cancer Analysis Offers New Diagnostic, Therapeutic Insights
Colon cancer ranks third in prevalence and fourth in cancer deaths among all cancers worldwide. However, due to its extreme heterogeneity, progress has been slow towards precision diagnostics and treatments.
![Whole exome sequencing is becoming more available to patients and will help them distill the sequencing data to candidate genes and link them with therapies. [NCI]](https://www.clinicalomics.com/wp-content/uploads/2019/01/596-218x150.jpeg "Cancer Combination Therapies Tailored to Individuals Show Improved Outcomes")
Cancer Combination Therapies Tailored to Individuals Show Improved Outcomes
Patients with therapy-resistant cancers show improved outcomes if their treatments are personalized according to the molecular profile of their cancer, according to a new...
PerkinElmer, Helix Partner to Launch Genetic Screening Test
The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
Genetic Testing for Ovarian Cancer Patients is Underused
Patients with ovarian cancer are not getting all the testing they need, according to study a recently published in Journal of Clinical Oncology.
Breast and...
